A Phase I Trial of Farnesyltransferase Inhibitor, R115777 (NSC # 702818) and Radiotherapy in Patients With Non-Small Cell Lung Cancer

Trial Profile

A Phase I Trial of Farnesyltransferase Inhibitor, R115777 (NSC # 702818) and Radiotherapy in Patients With Non-Small Cell Lung Cancer

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Oct 2009

At a glance

  • Drugs Tipifarnib (Primary)
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 13 Oct 2009 Additional lead trial centre (Abramson Cancer Center of the University of Pennsylvania) investigator (Hahn SM) identified as reported by ClinicalTrials.gov.
    • 04 Jun 2007 Status changed from in progress to completed.
    • 08 May 2007 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top